Skip to main content
. 2019 Jun 11;19:97. doi: 10.1186/s12871-019-0767-x

Fig. 2.

Fig. 2

Blood product use in survivors and nonsurvivors of orthotopic liver transplantation. Nonsurvivors were more likely to receive fibrinogen concentrates, PCC, platelet concentrates, and red blood cell concentrates. Differences between groups were evaluated using the unpaired Wilcoxon test. (PCC: prothrombin complex concentrate; RBC: red blood cell concentrate)